Literature DB >> 25550586

Impact of lower mediastinal lymphadenectomy for the treatment of esophagogastric junction carcinoma.

Kei Hosoda1, Keishi Yamashita2, Natsuya Katada2, Hiromitsu Moriya2, Hiroaki Mieno2, Shinichi Sakuramoto2, Shiro Kikuchi2, Masahiko Watanabe2.   

Abstract

AIM: To define the optimal extent of resection for esophagogastric junction (EGJ) carcinoma. PATIENTS AND METHODS: We retrospectively reviewed medical records of 193 patients with EGJ adenocarcinoma or squamous cell carcinoma who underwent surgery at the Kitasato University. An index was calculated to evaluate the therapeutic value of lymphadenectomy.
RESULTS: The following factors were identified as independent predictors of poor survival: (y)pT3-4, (y)pN3, ly2-3, no performance of splenectomy and R1-2. Although metastases were found in mediastinal lymph-nodes in patients with esophageal invasion of ≤30 mm, the index was 0 for all mediastinal lymph-nodes. By contrast, in patients with esophageal invasion of >30 mm, the index was 13.9 for the No. 110 nodes, which was the second highest after the index for the No. 1 nodes.
CONCLUSION: In EGJ cancer patients with esophageal invasion of >30 mm, aggressive lower mediastinal lymphadenectomy with R0 resection is required to obtain the best result. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Esophagogastric junction; lymph node excision; neoplasms; prognosis; surgery

Mesh:

Year:  2015        PMID: 25550586

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

Review 1.  Overview of multimodal therapy for adenocarcinoma of the esophagogastric junction.

Authors:  Kei Hosoda; Keishi Yamashita; Natusya Katada; Masahiko Watanabe
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-08-01

2.  Short-term outcomes after laparoscopic versus open transhiatal resection of Siewert type II adenocarcinoma of the esophagogastric junction.

Authors:  Shizuki Sugita; Takahiro Kinoshita; Akio Kaito; Masahiro Watanabe; Hideki Sunagawa
Journal:  Surg Endosc       Date:  2017-06-27       Impact factor: 4.584

3.  Efficacy analysis of Cheng's GIRAFFE reconstruction after proximal gastrectomy for adenocarcinoma of esophagogastric junction.

Authors:  Zhiyuan Xu; Can Hu; Yanqiang Zhang; Ling Huang; Litao Yang; Jianfa Yu; Pengfei Yu; Jiahui Chen; Yian Du; Xiangdong Cheng
Journal:  Chin J Cancer Res       Date:  2022-06-30       Impact factor: 4.026

4.  Laparoscopic vs. open lower mediastinal lymphadenectomy for Siewert type II/III adenocarcinoma of esophagogastric junction: An exploratory, observational, prospective, IDEAL stage 2b cohort study (CLASS-10 study).

Authors:  Shuangxi Li; Xiangji Ying; Fei Shan; Yongning Jia; Zhemin Li; Kan Xue; Rulin Miao; Yinkui Wang; Zhaode Bu; Xiangqian Su; Ziyu Li; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2022-08-30       Impact factor: 4.026

5.  New evidence guiding extent of lymphadenectomy for esophagogastric junction tumor: Application of Ber-Ep4 Joint with CD44v6 staining on the detection of lower mediastinal lymph node micrometastasis and survival analysis.

Authors:  Bin Zheng; Chen-Hui Ni; Hao Chen; Wei-Dong Wu; Zhao-Hui Guo; Yong Zhu; Wei Zheng; Chun Chen
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

6.  Optimal treatment for Siewert type II and III adenocarcinoma of the esophagogastric junction: A retrospective cohort study with long-term follow-up.

Authors:  Kei Hosoda; Keishi Yamashita; Hiromitsu Moriya; Hiroaki Mieno; Masahiko Watanabe
Journal:  World J Gastroenterol       Date:  2017-04-21       Impact factor: 5.742

7.  Long-term Outcomes of Laparoscopic Versus Open Transhiatal Approach for the Treatment of Esophagogastric Junction Cancer.

Authors:  Yoontaek Lee; Sa-Hong Min; Ki Bum Park; Young Suk Park; Sang-Hoon Ahn; Do Joong Park; Hyung-Ho Kim
Journal:  J Gastric Cancer       Date:  2019-01-31       Impact factor: 3.720

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.